Diagnosis and treatment of autoimmune hemolytic anemia: Classic approach and recent advances

Blood Research

Volumn 51, Issue 2, 2016, Pages 69-71

  Park, Sang Hyuk ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIANEMIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; MYCOPHENOLATE MOFETIL; OFATUMUMAB; RITUXIMAB;

ANEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; COOMBS TEST; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; RETICULOCYTOSIS; SPHEROCYTOSIS;

EID: 84977578964     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2016.51.2.69     Document Type: Article

References (10)

1. Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood 2010;116:1831-8.
2. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica 2014;99:1547-54.
3. Bass GF, Tuscano ET, Tuscano JM. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev 2014;13: 560-4.
4. Roback JD, Barclay S, Hillyer CD. An automatable format for accurate immunohematology testing by flow cytometry. Transfusion 2003;43:918-27.
5. Thedsawad A, Taka O, Wanachiwanawin W. Development offlow cytometry for detection and quantitation of red cell bound immunoglobulin G in autoimmune hemolytic anemia with negative direct Coombs test. Asian Pac J Allergy Immunol 2011;29:364-7.
6. Aladjidi N, Leverger G, Leblanc T, et al. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 2011;96: 655-63.
7. Conley CL, Lippman SM, Ness P. Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency. JAMA 1980;244: 1688-90.
8. Salama A. Treatment options for primary autoimmune hemolytic anemia: a short comprehensive review. Transfus Med Hemother 2015;42:294-301.
9. Park SH, Choe WH, Kwon SW. Red blood cell transfusion in patients with autoantibodies: Is it effective and safe without increasing hemolysis risk? Ann Lab Med 2015;35:436-44.
10. Prabhu R, Bhaskaran R, Shenoy V, G R, Sidharthan N. Clinical characteristics and treatment outcomes of primary autoimmune hemolytic anemia: a single center study from South India. Blood Res 2016;51:88-94.